检索结果-南通市图书馆

检索条件"主题词=microscopic surgery"

共 1 条记录，以下是1-10 订阅

全选清除本页清除全部题录导出标记到"检索档案"

详细简洁

排序：

Are dopamine agonists still the first-choice treatment for prolactinoma in the era of endoscopy? a systematic review and meta-analysis

Are dopamine agonists still the first-choice treatment for p...

引用

第十六届中国医师协会神经外科医师年会

作者： Xiangming Cai Jinhao Zhu Jin Yang Chao Tang Zhixiang Cong Chiyuan Ma School of Medicine Southeast University School of Medicine Nanjing Medical University School of Medicine Nanjing University

Objective:For prolactinoma patients,dopamine agonists(DAs) are indicated as the first-line treatment and surgery is an adjunctive choice.However,with the development of surgical technique and equipment,the effect of surgery has improved.The aim of this study was to assess the efficacy and safety of surgery versus DAs in patients with different types of prolactinomas.Methods:A systematic search of literature using Web of Science,PubMed,Cochrane Library,and Clinical Trial databases was conducted until July 12,2019.Prolactinoma patients treated with DAs(bromocriptine or cabergoline) or surgery(microscopic or endoscopic surgery) were included.Outcomes included the biochemical cure rate,recurrence rate,prolactin level,improvement rates of symptoms,and incidence rates of complications.A random-effects model was used to pool the extracted data.Qualitative comparisons were conducted instead of quantitative comparison.Results:DAs were better than surgery in terms of the biochemical cure rate(0.78 versus 0.66),but surgery had a much lower recurrence rate(0.19 versus 0.57).Full advantages were not demonstrated in improvement rates of symptoms and incidence rates of complications with both treatment options.In microprolactinoma patients,the biochemical cure rate of endoscopic surgery was equal to the average cure rate of DAs(0.86 versus 0.86) and it surpassed the biochemical cure rate of bromocriptine(0.86 versus 0.76).In macroprolactinoma patients,endoscopic surgery was slightly higher than bromocriptine(0.66 versus 0.64) in terms of the biochemical cure rate.Conclusion:For patients with clear indications or contraindications for surgery,chossing surgery or DAs accordingly is unequivocal.However,for patients with clinical equipoise,such as surgery,especially endoscopic surgery,in microprolactinoma and macroprolactinoma patients,we suggest that neurosurgeons and endocrinologists conduct high quality clinical trials to address the clinical equipoise quantitatively.

关键词： prolactinoma dopamine agonists bromocriptine cabergoline microscopic surgery endoscopic surgery

来源： cnki会议评论

在线全文

cnki会议

学校读者我要写书评

暂无评论

全选清除本页清除全部题录导出标记到“检索档案”

共1页 << < 1 > >>

回到顶部

执行限定条件

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：